ARTICLE | Company News
Abeona Therapeutics, University of Nebraska deal
July 20, 2015 7:00 AM UTC
The UNeMed Corp. tech transfer arm of the university’s medical center granted Abeona exclusive, worldwide rights to develop and commercialize ABO-201 to treat juvenile Batten disease. The parties dec...